CN1187829A - 杂远螯嵌段共聚物及其制备方法 - Google Patents
杂远螯嵌段共聚物及其制备方法 Download PDFInfo
- Publication number
- CN1187829A CN1187829A CN96194818A CN96194818A CN1187829A CN 1187829 A CN1187829 A CN 1187829A CN 96194818 A CN96194818 A CN 96194818A CN 96194818 A CN96194818 A CN 96194818A CN 1187829 A CN1187829 A CN 1187829A
- Authority
- CN
- China
- Prior art keywords
- formula
- segmented copolymer
- integer
- heterotelechelic
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
- C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
- C08G65/2606—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
- C08G65/2609—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups containing aliphatic hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S525/922—Polyepoxide polymer having been reacted to yield terminal ethylenic unsaturation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polyesters Or Polycarbonates (AREA)
- Graft Or Block Polymers (AREA)
- Polymerisation Methods In General (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Materials For Medical Uses (AREA)
Abstract
公开了下式所示的杂远螯低聚物或聚合物,式中R1和R2是形成缩醛,或者合在一起形成氧代(=O)的原子团,p、m、n和q是一定的数,L是形成酯的基团,Z是一定的官能团。而且,也公开了这些通过活性聚合制备的方法。这些低聚物或聚合物能在水基溶剂中形成稳定的高分子胶束,因而,例如,可用作药物的标的指向性载体。
Description
技术领域
本发明涉及两端有不同官能团的杂远螯嵌段共聚物及其制备方法,及其对高分子胶束的应用。更具体地说,本发明公开了两端有不同官能团、主链上有聚环氧乙烷作为亲水链段和聚酯作为疏水链段的聚合物。
此外,本发明中所谓聚合物这一术语,是以包含低聚物的概念使用的。
背景技术
聚环氧乙烷这样的亲水性高分子与其它疏水性高分子在分子水平上结合的亲水/疏水型嵌段共聚物所组成的高分子胶束或纳米球(nanosphere),作为药物载带用载体等,日益引人瞩目。高分子胶束和纳米球的调整,是通过亲水性聚合物与疏水性聚合物在分子水平上结合的亲水/疏水型嵌段共聚物实现的。
然而,先有技术上亲水/疏水型嵌段共聚物的制备方法在导入其末端官能团方面是有限制的,已提出来的只不过是有甲氧基或羟基等所限定官能团的嵌段共聚物。具体地说,若能在胶束表面上成功地以任意比例导入任意反应性官能团,则将有可能提供可有利地用于医药等的活体内标的指向化的功能高分子胶束。
因此,本发明的目的,是提供两端有不同的官能团的嵌段共聚物,作为能形成高分子胶束的多功能高分子。
发明公开
本发明者等人发现,如果利用某种有醛基和羟基的亚烷基衍生物作为活性聚合的引发剂来使作为单体的环氧乙烷、丙交酯或内酯聚合,则可以容易地提供分子的一端为也可以有保护的醛基、而另一端为多种多样官能团的嵌段共聚物。
而且也确认,这样得到的嵌段共聚物在水基溶剂中形成极其稳定的高分子胶束。
式中R1和R2独立地表示C1-10烷氧基、芳氧基或芳基-C1-3烷氧基,或者R1与R2合在一起表示也可以有C1-6烷基取代的亚乙二氧基(-O-CH(R′)-CH-O-:其中R′表示氢原子或C1-6烷基),或者R1与R2合在一起表示氧代(=O),L表示
其中R3和R4独立地表示氢原子、C1-10烷基、芳基或芳基-C1-3烷基,r是2~5的整数,
m是2~10,000的整数,
n是2~10,000的整数,
p是1~5的整数,
q是0或1~20的整数,而
Z当q为0时是氢原子、碱金属、乙酰基、丙烯酰基、甲基丙烯酰基、肉桂酰基、对甲苯磺酰基、2-巯基丙酰基或2-氨基丙酰基,或表示烯丙基或乙烯基苄基,而当q为1~20的整数时是C1-6烷氧羰基、羧基、巯基或氨基。
按照本发明,作为发明的另一个方面,也提供了上述式(I)的嵌段共聚物的制备方法。该方法包括如下步骤:
步骤(1):
式(II)的聚合引发剂与环氧乙烷反应,生成式(III)所示化合物,式中R1-1和R2-1独立地表示C1-10烷氧基,或者R1-1与R2-1合在一起表示也可以有C1-6取代的亚乙二氧基,p是1~5的整数,而M表示碱金属,式中R1-1、R2-1、p和M均如对式(II)所定义的,而m是2~10,000的整数;
步骤(2):
式(II)所示化合物与下式所示丙交酯或内酯反应,或
式中R3和R4独立地表示氢原子、C1-10烷基、芳基或芳基-C1-3烷基,而r表示2~5的整数,生成下式所示的嵌段共聚物,式中L表示式
或
R1-1、R2-1、p、m、n和M均如上述所定义。
通过以上步骤,提供了本发明的活性聚合物(包含在式(I)聚合物中),这也可以作为中间原料进一步用于使任何聚合物链段伸长。
步骤(3):
在实施这些步骤时,可以得到在分子的α-末端有受保护醛基或醛基本身,在ω-末端有羟基的本发明嵌段共聚物。
步骤(4):使式(V)的α-末端上有受保护醛基的嵌段共聚物
(i)与乙酸、丙烯酸、甲基丙烯酸、肉桂酸或对甲苯磺酸或其活泼衍生物反应,
(ii)与烯丙基卤或乙烯基苄基卤反应,或
提供在分子的ω-末端有除羟基以外的各自对应官能团的本发明嵌段共聚物。
步骤(5):步骤(4)的(i)得到的对甲苯磺酸酯通过酯交换等可以提供在ω-末端还有其它官能团(例如巯基、氨基)的嵌段共聚物,而通过以上步骤得到的有醛保护基或羧基保护基的嵌段共聚物还可以再借助于水解反应使任何一个保护基或全部保护基脱除,而提供本发明的嵌段共聚物。
按照本发明,作为发明的又一个方面,也提供利用式(I)所示嵌段共聚物可以得到的高分子胶束。
这样得到的本发明杂远螯聚合物的一部分可以作为前体物用于制备另一种聚合物,而且如同从其构成成分可以理解的,这些聚合物具有活体亲和性,而且可以预期其生物有效性高。因此,可以用于诸如活体内直接适用的材料,例如医药载带用载体材料等,而且,尤其按照本发明的第三方面,由于可以提供在水基溶剂中极其稳定的高分子胶束,因而也可用作活体内标的指向性医药载体。
附图简单说明
图1是缩醛α-末端/羟基ω-末端聚酯氧化物/聚丙交酯嵌段共聚物(实施例1的样品)的凝胶渗透色谱图。
操作条件:
柱:TSK-Gel(G4000HXL、G3000HXL、G2500HXL)
流出溶剂:THF(含2%三乙胺)
流速:1ml/分钟。
图2是缩醛α-末端/羟基ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例1的样品)的质子核磁共振谱。
图3是缩醛α-末端/羟基ω-末端聚环氧乙烷/聚(δ-戊内酯)嵌段共聚物(实施例3的样品)的质子核磁共振谱。
图4是醛α-末端/羟基ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例4的样品)的质子核磁共振谱。
图5是缩醛α-末端/甲基丙烯酰ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例5的样品)的碳核磁共振谱。
图6是缩醛α-末端/烯丙基ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例6的样品)的碳核磁共振谱。
图7是缩醛α-末端/对甲苯磺酰ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例6的样品)的碳核磁共振谱。
图8是醛α-末端/羟基ω-末端聚环氧乙烷/聚丙交酯嵌段共聚物(实施例4的样品)的水溶液中高分子胶束粒度分布的动态激光光散射测定结果示意图。
发明详细说明
本发明中所谓烷氧基的烷基部分和烷基,系指直链或枝链烷基。因此,式(II)、式(IIIa)中C1-10烷氧基的烷基部分或C1-10烷基,可以列举甲基、乙基、丙基、异丙基、丁基、仲丁基、叔丁基、戊基、异戊基、己基、2-甲基戊基、3-甲基戊基、辛基、2-乙基己基、癸基或4-丙基戊基。这些当中,R1和R2中所谓烷氧基的烷基部分,较好的是C1-6烷基,尤其好的是C1-3烷基。
因此,R1和R2中所谓烷氧基,尤其好的可以列举甲氧基、乙氧基、丙氧基、异丙氧基。而R1和R2可以列举芳基、尤其苯基、或芳基C1-3烷基、尤其苄基或苯乙基,作为其较好者。这些基团可以相同也可以不同,但较好是相同基团。而且R1和R2合在一起,可以是也可以有C1-6烷基取代的亚乙二氧基(-OCH(R′)-CH2O-:式中R′是C1-6烷基),较好是亚乙二氧基、亚丙二氧基、1,2-亚丁二氧基。
这些基团可以通过水解,方便地使R1和R2合在一起形成氧代(=O),即形成分子的α-末端有醛基的本发明嵌段共聚物。
式(I)的p表示1~5的整数,但式(I)的链段若考虑到其源于本发明制备方法中的聚合引发剂(参照式(II)),则这个链段作为整体,较好是选择R1、R2和p,使之能构成缩醛基,例如二甲氧甲氧基、2,2-二甲氧乙氧基、3,3-二甲氧丙氧基、4,4-二甲氧丁氧基、二乙氧甲氧基、2,2-二乙氧乙氧基、3,3-二乙氧丙氧基、4,4-二乙氧丁氧基、二丙氧甲氧基、2,2-二丙氧乙氧基、3,3-二丙氧丙氧基或4,4-二丙氧丁氧基等。
另一方面,R3和R4只要符合本发明之目的者,可以是氢原子、C1 -10烷基、芳基或芳基-C1-3烷基中的任何一种,但从生物有效性的观点来看,较好是氢原子(源于戊二酸)和甲基(源于乳酸)。
式(I)中的m,按照本发明经由活性聚合的制备方法,通过调整环氧乙烷(单体)相对于聚合引发剂的数量比例,理论上可以达到任意的m值,但依照本发明之目的,m较好的是2~10,000之间的任何一个整数。这个链段能赋予本发明嵌段共聚物以亲水性的m,较好的是10以上的整数。而就易于在狭窄范围内调整这个链段的分子量分布和能提供生物有效性优异的嵌段共聚物而言,应选择得使m为500以下,较好为200以下的整数。
另一方面,定义式(I)中聚酯链段的分子量的n,可以从这个链段主要赋予本发明嵌段共聚物以疏水性这一点来理解,最佳n值要因R3和R4的基团性质而异。此外,在本发明的聚合方法中,例如,可以同聚环氧乙烷链段一样选取任意的n值。因此,n值是没有限定的,但通常是2~10,000。进而,就其与聚环氧乙烷链段的关系而言,为了较好地保持亲水性-疏水性的平衡,较好选取n为10~200的整数、尤其10~100的整数。式(I)的
链段主要规定本发明嵌段共聚物的ω-末端官能团(或活泼基团)。在q为0(即Z与聚酯链段的ω-位氧原子直接结合)的情况下,首先可以是碱金属。这种情况下的本发明聚合物可以是活性聚合物(living polymers)。因此,这样的本发明聚合物可以进一步充当活性聚合(living polymerization)的引发剂,因而也可进一步用作各种聚合物的前体物。从这种观点来看,作为碱金属,可以列举钠、钾和铯。
而且,上述活性聚合物容易在醇化物部分发生水解,因而容易提供Z表示氢原子的化合物(ω末端是羟基)。进而,这种羟基还可以通过各种反应,例如酯化、醚化,而转化成其它官能团。因此,作为q为0情况下的Z,可以是乙酰基(-COCH3)、丙烯酰基(-COCH=CH2)、甲基丙烯酰基(-COC(CH3)=CH2)、肉桂酰基(-CHCH=CH
)和对甲苯磺酰基(-SO2 -CH3),还可以是烯丙基(-CH2-CH=CH2)和乙烯基苄基(-CH2 -CH=CH2)。在有这些官能团例如乙烯类不饱和键的情况下,可以利用它们衍生成侧链型聚合物。此外,在对甲苯磺酰基的情况下,通过酯交换等,还可以再用其本身已知的方法转化成其它官能团。因此,Z也可以是2-巯基丙酰基或2-氨基丙酰基。
在q为1-20的整数、较好1~4、尤其好的是2的整数的情况下,-(CH)qZ作为一个整体可以是C1-6烷氧基(例如甲氧基、乙氧基、丙氧基)羰基-甲基、-乙基或-丙基,或者是2-氨基乙基、羧-甲基、-乙基或-丙基。
以上各取代基(或链段)组合构成的本发明嵌段共聚物,可以列举下述表1中的实例。
表1化合物 R1 R2 p m*1) L n*2) No1 CH3CH2O CH3CH2O 2 280
40 H2 CH3CH2O CH3CH2O 2 280
40 K3 CH3CH2O CH3CH2O 2 280
70 H4 CH3CH2O CH3CH2O 2 280
70 K5 CH3CH2O CH3CH2O 2 280
70 COCH=CH26 CH3CH2O CH3CH2O 2 280
70 COC(CH3)=CH27 CH3CH2O CH3CH2O 2 280
70 CH2 8 CH3CH2O CH3CH2O 2 280
70 SO2 CH3
表1(续)化合物 R1 R2 p m*1) L n*2)
No9 CH3CH2O CH3CH2O 2 280
70
10 CH3CH2O CH3CH2O 2 280
70
11 CH3CH2O CH3CH2O 2 280
70 COCH312 CH3CH2O CH3CH2O 3 100
70 H13 CH3O CH3O 2 100
70 H14 CH3CH2O CH3CH2O 2 100
50 H15 CH3CH2O CH3CH2O 2 100
50 K16 CH3CH2O CH3CH2O 2 100
50 COCH=CH217 CH3CH2O CH3CH2O 2 100
50 COC(CH3)=CH218 O= 2 280
40 H19 O= 2 100
70 H
表1(续)化合物 R1 R2 p m*1) L n*2)
No20 O= 2 100
70 COCH=CH221 O= 2 100
70 COC(CH3)=CH222 O= 2 100
70 CH2 23 O= 2 100
70 COCH324 O= 3 100
70 H25 O= 2 100
50 H26 O= 2 100
50 COCH=CH227 O= 2 100
50 COC(CH3)=CH2 *1)和*2)表示从数均分子量换算的值。
从(A)制备(B):
使碱金属缩醛保护醇盐(A)与环氧乙烷反应,得到加成了聚环氧乙烷链段的化合物(B)。化合物(A)可以用金属化剂如钠或钾等碱金属,萘基钠、萘基钾、枯基钾、枯基铯等有机金属,氢化钠、氢化钾等金属氢化物等,处理缩醛保护醇来得到。
此外,上述从(A)变成(B)的反应可以在无溶剂下或较好在无水的非质子传递溶剂中,在广泛的温度例如-50℃~300℃、较好10℃~60℃、方便而好的是在室温(20~30℃)下进行。反应可以在加压下或减压下实施。使用的溶剂没有限定,但可以列举诸如苯、甲苯、二甲苯、四氢呋喃、二噁烷、乙腈等。反应容器没有特别限定,可以使用诸如圆底烧瓶、高压釜、耐压封管等。反应容器内较好能与外界大气隔断,若能充满惰性气体则更好。反应溶液的浓度较好是0.1~95%(重量)、更好的是1~80%(重量)、最好的是3~10%(重量)。
从(B)制备(C):
含有(B)的反应混合物与丙交酯或内酯反应,得到聚酯链段通过聚环氧乙烷的ω末端羟基加成的活性嵌段共聚物(C)。其反应条件可以与上述(A)变成(B)的反应几乎完全一样。可以使用的丙交酯和内酯是能形成式(I)中L的R3和R4所定义的链者。丙交酯较好的虽没有限定,但可以是乳酸丙交酯和乙醇酸丙交酯。另一方面,可以使用的内酯是β-丙酸内酯、γ-丁酸内酯、δ-戊酸内酯和ε-己酸内酯。从反应容易性的观点来看,较好的是γ-丁酸内酯和δ-戊酸内酯。
以上各步骤中聚合引发剂与环氧乙烷或丙交酯或内酯的使用比例,以摩尔比计,较好分别为1∶1至1∶10,000,更好的是1∶5至1∶10,000,最好的是1∶10~200至1∶50~200。
按照本发明的方法,不仅各链段可以分别根据单体与引发剂的相对用量来调整分子量,而且可以提供所生成各链段的分子量分布非常狭窄、单分散性或一峰性嵌段共聚物。
这样得到的活性聚合物(C)本身也包含在本发明的聚合物范围内,但(C)的醇化物可以(i)在温和条件(只简单地加水)下部分水解而转化成聚合物(D),或者(ii)在可以同时使缩醛水解的条件下处理(C)而转化成α-末端有醛基、ω-末端有羟基的聚合物(D′)。后者的水解可以使用三氟乙酸、盐酸、硫酸、硝酸、甲酸、氟化氢等酸类,氢氧化钠、氢氧化钾等碱类,必要时加热处理来进行。
从(D)制备(E)~(G):
(i)在惰性有机溶剂中与乙酸、丙烯酸、甲基丙烯酸或对甲苯磺酸反应,生成ω-末端酰基化物,或
(ii)与下式的卤化物反应,提供ω-末端醚化物,
halo-E (V)式中halo与E对应于式(I)中-(CH2)q-Z除酰基以外的基团。
这些反应可以按照其本身已知的酯化或醚化法进行。此外,上述(i)的有机酸,方便的是使用各自的酸酐或酰卤等有机酸的活泼衍生物。
而且,当ω-末端导入巯基时,可以诸如使对甲苯磺酰化物(F)与亲电子试剂例如硫代乙酸钠、硫代乙酸钾、硫氢化钾等亲电子剂反应,从而在ω末端导入硫代酯基,然后,用碱或酸处理,得到(G)所示的聚合物。
当ω-末端导入氨基时,可以利用N-(2-溴乙基)邻苯二甲酰亚胺、N-(3-溴丙基)邻苯二甲酰亚胺、1-溴-2-(苯胺基)乙烷、N-(2-溴乙基)氨基甲酸苄酯等作为亲电子试剂进行(D)的水解,然后用碱或酸处理进行基团R1和R2的脱保护,同时进行ω-末端酰亚胺键的水解,得到ω-末端有氨基的聚合物。
聚合物(D)、(E)、(F)和(G)上基团R1和R2脱保护产生α-末端醛,可以按照上述从(C)向(D′)的转化那样进行。反应液中聚合物的回收,可以借助于其本身的溶剂沉淀法或凝胶渗透色谱法、渗析、超过滤等来进行。
这样,便可以得到本发明式(I)所示的各种杂远螯嵌段共聚物。所得到的聚合物(除活性聚合物外)可以在水基溶剂中形成极稳定的高分子胶束。
这种高分子胶束可以通过诸如对聚合物溶液或悬浮液以单独或组合方式进行加温处理、超声波照射处理、有机溶剂处理等来制备。加温处理,是使本发明嵌段共聚物中的1种或2种以上的混合物分散或溶解在水中,在30~100℃的温度、更好的是在30℃~50℃的温度调制。超声波照射处理,是使嵌段共聚物中的1种或2种以上的混合物分散在水中,在1W~20W的范围进行1秒~24小时,较好在1W~3W的范围进行3小时。
有机溶剂处理,是使嵌段共聚物中的1种或2种以上的混合物溶解在有机溶剂中,再将此溶液分散于水中,然后蒸发有机溶剂。作为有机溶剂,可以使用氯仿、苯、甲苯和二氯甲烷等。
此外,还可以通过溶解于甲醇、乙醇、四氢呋喃、二噁烷、二甲基亚砜、二甲基甲酰胺等中,然后对水基溶剂渗析,来制备本发明的高分子胶束。渗析中使用的渗析膜的分级分子量,其最佳值因作为处理对象的嵌段共聚物的分子量而异,因而没有予以限定,但一般可以使用1,000,000以下,较好5,000~20,000。
作为水基溶剂,可以使用水、缓冲溶液,渗析时,相对于所使用的上述有机溶剂而言,水基溶剂的使用比例一般是1~1000倍、较好是10~100倍。温度没有特别限定,但通常可以在5℃~25℃进行。
这样得到的本发明高分子胶束,一般来说,其临界胶束浓度极低,低达4~12mg/l,而且与作为药物载体广泛探讨的脂质体等低分子胶束相比,在水基溶剂中是显著稳定的。这意味着,例如,在本发明高分子胶束对血中给药的情况下,可以期待其在血中的半衰期显著增大,因而可以说本发明聚合物具备作为药物载体的优异特性。
以下列举具体例来更具体地说明本发明,但无意使本发明局限于这些实例。
实施例1
向反应容器中加入THF 20ml和3,3-二乙氧基丙醇0.15g,以及萘基钾0.5mol/升四氢呋喃溶液2ml,在氩气氛围下搅拌3分钟,生成3,3-二乙氧基丙醇的钾化物(3,3-二乙氧基丙醇钾)。
向此溶液中加入环氧乙烷8.8g,在一大气压和室温下进行搅拌。反应2天后,向此反应液中添加丙交酯7.2g,进一步搅拌1小时。将此溶液倾入冷丙醇中,使所生成的聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其产率为15.0g(94%)。用凝胶渗透色谱法得到的聚合物是一峰性的,聚合物的数均分子量是约1600(参照图1)。
所得到的聚合物在氘代氯仿中的质子核磁共振谱证实,这种聚合物是有聚环氧乙烷(PEO)和聚丙交酯(PL)这两种单元、而且定量具有α-末端缩醛基和ω-末端羟基的杂远螯低聚物(参照图2)。从这种谱的积分比求出的嵌段共聚物各链段的数均分子量是PEO为约8800,PL为约7000。
实施例2
向反应容器中加入THF 20ml和3,3-二乙氧基丙醇0.15g,以及萘基钾0.5mol/升四氢呋喃溶液2ml,在氩气氛围下搅拌3分钟,生成3,3-二乙氧基丙醇的钾化物(3,3-二乙氧基丙醇钾)。
向此溶液中加入环氧乙烷5.7g,在一大气压和室温下进行搅拌。反应2天后,向此溶液加入丙交酯7.2g,进一步搅拌1小时。将此溶液倾入冷丙醇中,使所生成的聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率是12.4g(95%)。凝胶渗透色谱法得到的聚合物是一峰性的,聚合物数均分子量是约1200。
所得到的聚合物在氘代氯仿中的质子核磁共振谱证实,这种聚合物是有聚环氧乙烷(PEO)和聚丙交酯(PL)这两种单元、而且定量地具有α-末端缩醛基和ω-末端羟基的杂远螯低聚物。从这种谱的积分比求出的嵌段共聚物各链段的数均分子量是PEO为约5400,PL为约6600。
实施例3
向反应容器中加入THF 20ml和3,3-二乙氧基丙醇0.15g,以及萘基钾0.5mol/升四氢呋喃溶液2ml,在氩气氛围下搅拌3分钟,生成3,3-二乙氧基丙醇的钾化物(3,3-二乙氧基丙醇钾)。
向此溶液中加入环氧乙烷8.8g,在一大气压和室温下进行搅拌。反应2天后,向此溶液中添加δ-戊内酯5.0g,进一步搅拌1小时。将此溶液倾入冷丙醇中,使生成的聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率为13.5g(97%)。凝胶渗透色谱法得到的聚合物是一峰性的,聚合物的数均分子量为约1400。
所得到的聚合物在氘代氯仿中的质子核磁共振谱证实,这种聚合物是有聚环氧乙烷(PEO)和聚-δ-戊内酯(PVL)这两种单元、定量地具有α-末端缩醛基和ω-末端羟基的杂远螯低聚物(参照图3)。从这种谱的积分比求出的嵌段聚合物各链段的数均分子量是PEO为约8800,PVL为约5200。
实施例4
向溶解了实施例2得到的嵌段共聚物样品1.0g的甲醇50毫升中添加2.0mol/L HCl 50ml,在室温搅拌1小时。此溶液用NaOH水溶液中和后,对20倍量的水进行4小时渗析(分级分子量1000),用冷冻干燥法精制。其收率为0.85g(85%)。凝胶渗透色谱法得到的聚合物分子量与反应前相比,可以认为没有变化。
所得到的聚合物在氘代氯仿中的质子核磁共振谱证实,这种聚合物的α-末端缩醛基消失,取而代之的是出现由醛产生的峰,是定量地具有α-末端醛基和ω-末端羟基的杂远螯PEO/PL低聚物(参照图4)。
实施例5
向溶解了实施例2得到的嵌段共聚物样品1.0g的氯仿20毫升中添加吡啶20毫升和甲基丙烯酸酐1.0g,在室温搅拌24小时。此溶液用盐酸水溶液中和、洗涤。将氯仿相 注入冷丙醇中,使聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率为0.8g(80%)。凝胶渗透色谱法得到的聚合物分子量与反应前相比,可以认为没有变化。
所得到的聚合物在氘代氯仿中的碳核磁共振谱证实,这种聚合物的ω-末端羟基所产生的峰完全消失,取而代之的是出现由甲基丙烯酰基产生的峰,是定量地具有α-末端缩醛基和ω-末端甲基丙烯酰基的杂远螯PEO/PL低聚物(参照图5)。
实施例6
向溶解了实施例2得到的嵌段共聚物样品1.0g的四氢呋喃溶液20毫升中添加萘基钾0.5摩尔/升四氢呋喃溶液2毫升和烯丙基溴5毫升,在室温搅拌4小时。所得到的反应物倾入冷丙醇中,使聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率为0.98g(98%)。凝胶渗透色谱法得到的聚合物分子量与反应前相比,可以认为没有变化。
所得到的聚合物在氘代氯仿中的碳核磁共振谱证实,这种聚合物的ω-末端羟基所产生的峰完全消失,取而代之的是出现烯丙基所产生的峰,是定量地具有α-末端缩醛基和ω-末端烯丙基的杂远螯PEO/PL低聚物(参照图6)。
实施例7
向溶解了实施例4得到的嵌段共聚物样品1.0g的四氢呋喃20毫升中添加萘基钾0.5mol/L-四氢呋喃溶液2ml和对甲苯磺酰氯5g,在室温搅拌4小时。所得到的反应物倾入冷丙醇中,使聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率为0.95g(95%)。凝胶渗透色谱法得到的聚合物分子量与反应前相比,可以认为没有变化。
所得到的聚合物在氘代氯仿中的碳核磁共振谱证实,这种聚合物的ω-末端羟基所产生的峰完全消失,取而代之的是出现对甲苯磺酰基产生的峰,是定量地具有α-末端缩醛基和ω-末端对甲苯磺酰基的杂远螯PEO/PL低聚物(参照图7)。
实施例8
将实施例2得到的嵌段共聚物样品50mg溶解在水或适当缓冲溶液中,使其浓度为0.01~0.1%(重量/体积)。当通过动态光散射粒度分布测定确认这些溶液中的胶束形成时,可以确认形成了平均粒径30nm的单一好分子胶束(参照图8)。这种高分子胶束的临界胶束浓度是10mg/L。
实施例9
向反应容器中加入THF 30毫升和3,3-二乙氧基丙醇0.13g以及萘基钾0.5mol/L-四氢呋喃溶液2ml,在氩气氛围下搅拌3分钟,生成3,3-二乙氧基丙醇的钾化物(3,3-二乙氧基丙醇钾)。
向此溶液中添加环氧乙烷7.0g,在一大气压、室温下进行搅拌。反应2天后,向此反应液中添加乳酸丙交酯7.2g,进一步搅拌一小时。将此溶液倾入冷丙醇中,使所生成的聚合物沉淀。离心分离得到的沉淀用苯冷冻干燥进行精制。其收率为11.5g(79%)。凝胶渗透色谱法得到的聚合物是一峰性的,聚合物的数均分子量为11000。
所得到的聚合物在氘代氯仿中的质子核磁共振谱证实,这种聚合物是有聚环氧乙烷(PEO)和聚丙交酯(PL)这两种单元、定量地具有α-末端缩醛基、ω-末端羟基的杂远螯低聚物。从这种光谱的积分比求出的嵌段共聚物各链段的数均分子量是PEO为5800,PL为5100。
所得到的嵌段聚合物200mg溶解在二甲基乙酰胺40ml中,用分级分子量12000~14000的渗析膜对水进行24小时渗析(2、5、8小时后水交换各2升)。所得到的溶液的动态光散射测定表明精制了平均粒径40nm的高分子胶束。其临界胶束浓度是5mg/L。
实施例10
实施例9得到的胶束溶液10ml中滴加0.1N盐酸,调节至pH=2,在室温下搅拌2小时。用0.1N氢氧化钠水溶液中和,用分级分子量12000~14000的渗析膜对水渗析24小时(2、5、8小时后水交换各2升)。所得到的溶液的动态光散射测定表明精制了平均粒径40nm的高分子胶束。其临界胶束浓度为5mg/L。
此胶束溶液冷冻干燥,溶解在氘代二甲基亚砜中之后进行NMR测定时,1.2ppm和4.6ppm的缩醛基产生的信号几乎完全消失,并出现了2.7ppm(t)和9.8ppm(s)分别为羰基亚甲基和醛氢产生的信号。信号的面积比表明,缩醛的95%水解成醛。
实施例11
同实施例1一样合成的PEO/PAL嵌段聚合物(数均链段的数均分子量PEO为4500,PLA为13000)200mg溶解在二甲基乙酰胺40ml中,用分级分子量12000~14000的渗析膜对水渗析24小时(2、5、8小时后水交换各2升)。所得到的溶液的动态光散射测定表明,精制了平均粒径30nm的高分子胶束。其临界胶束浓度为4mg/L。
产业上利用的可能性
按照本发明,提供了分子两末端有不同官能团、且主链上有亲水性链段和疏水性链段的杂远螯低聚物或聚合物。这些低聚物或聚合物,从其构成成分可以预期是生物有效性优异的。此外,这些低聚物或聚合物在水基溶剂中可以形成极稳定的高分子胶束。
因此,在适用于生物体,例如制造和/或使用药物标的指向性载体的技术领域,可以利用的可能性高。
Claims (13)
式中R1和R2独立地表示C1-10烷氧基、芳氧基或芳基-C1-3烷氧基,或者R1与R2合在一起表示也可以有C1-6烷基取代的亚乙二氧基(-O-CH(R′)-CH-O-:其中R′表示氢原子或C1-6烷基),或者R1与R2合在一起表示氧代(=O),L表示
或
其中R3和R4独立地表示氢原子、C1-10烷基、芳基或芳基-C1-3烷基,r是2~5的整数,
m是2~10,000的整数,
n是2-10,000的整数,
p是1~5的整数,
q是0或1~20的整数,而
Z当q为0时是氢原子、碱金属、乙酰基、丙烯酰基、甲基丙烯酰基、肉桂酰基、对甲苯磺酰基、2-巯基丙酰基或2-氨基丙酰基,或表示烯丙基或乙烯基苄基,而当q为1~20的整数时是C1-6烷氧羰基、羧基、巯基或氨基。
2.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2合在一起表示氧代。
3.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2独立地表示C1-6烷氧基、苯氧基、苄氧基,或者R1和R2合在一起表示也可以有C1-3烷基取代的亚乙二氧基。
4.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2合在一起表示氧代,L中的R3和R4都是氢或甲基或者r是整数4,而q是0或1~3的整数。
5.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2独立地是C1-6烷氧基,L中的R3和R4都是氢或甲基或者r是整数4,而q是0或1~3的整数。
6.权利要求1所述的杂远螯嵌段共聚物,其中m表示10~200的整数,n表示10~200的整数。
7.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2合在一起表示氧代,L中的R3和R4都是氢或甲基或者r是整数4,q是0,而Z是氢原子、乙酰基、丙烯酰基、甲基丙烯酰基、肉桂酰基或对甲苯磺酰基,或者是烯丙基或乙烯基苄基。
8.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2独立地是C1-6烷氧基,L中的R3和R4都是甲基或者r是整数4,q是0,而Z是氢原子或钠、钾或铯。
9.权利要求1所述的杂远螯嵌段共聚物,其中R1和R2合在一起表示氧代,L中的R3和R4都是甲基或者r是整数4,q是1~3的整数,而Z是C1-6烷氧羰基、羧基、巯基或氨基。
10.权利要求1所述的式(I)所示杂远螯嵌段共聚物的制备方法,所述方法包括下列步骤:
步骤(1):
式(II)的聚合引发剂与环氧乙烷反应,生成式(III)所示化合物,式中R1-1和R2-1独立地表示C1-10烷氧基,或者R1-1与R2-1合在一起表示也可以有C1-6取代的亚乙二氧基,p是1~5的整数,而M表示碱金属,式中R1-1、R2-1、p和M均如对式(II)所定义的,而m是2~10,000的整数;
步骤(2):
式(II)所示化合物与下式所示丙交酯或内酯反应,或
式中R3和R4独立地表示氢原子、C1-10烷基、芳基或芳基-C1-3烷基,而r表示2~5的整数,生成下式所示的嵌段共聚物,式中L表示式
或
R1-1、R2-1、p、m、n和M均如上述所定义;
步骤(3):因情况而异,
步骤(4):使式(V)的α-末端上有受保护醛基的嵌段共聚物
(i)与乙酸、丙烯酸、甲基丙烯酸、肉桂酸或对甲苯磺酸或其活泼衍生物反应,
(ii)与烯丙基卤或乙烯基苄基卤反应,或
步骤(5):因情况而异,使步骤(4)的(i)生成的对甲苯磺酸酯发生酯交换,或者使步骤(4)的(i)、(ii)或(iii)得到的衍生物发生水解反应。
11.高分子胶束,其中含有权利要求1所述杂远螯嵌段共聚物作为水基溶剂中的活性成分。
12.权利要求9所述的高分子胶束,其中权利要求1所述杂远螯嵌段共聚物是式(I)的Z表示碱金属以外的基团者。
13.权利要求9所述的高分子胶束,其中权利要求1所述杂远螯嵌段共聚物是式(I)的Z为碱金属以外的基团、而R1与R2合在一起表示氧者。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP93928/95 | 1995-04-19 | ||
JP9392895 | 1995-04-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1187829A true CN1187829A (zh) | 1998-07-15 |
CN1085987C CN1085987C (zh) | 2002-06-05 |
Family
ID=14096103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96194818A Expired - Lifetime CN1085987C (zh) | 1995-04-19 | 1996-04-18 | 杂远螯嵌段共聚物及其制备方法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5925720A (zh) |
EP (1) | EP0822217B1 (zh) |
JP (1) | JP3855279B2 (zh) |
KR (1) | KR19990007861A (zh) |
CN (1) | CN1085987C (zh) |
AT (1) | ATE226603T1 (zh) |
AU (1) | AU5346896A (zh) |
BR (1) | BR9608330A (zh) |
CA (1) | CA2218495A1 (zh) |
DE (1) | DE69624475T2 (zh) |
HU (1) | HUP9801633A3 (zh) |
NO (1) | NO314762B1 (zh) |
NZ (1) | NZ305471A (zh) |
RU (1) | RU2169742C2 (zh) |
SI (1) | SI9620067A (zh) |
WO (1) | WO1996033233A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103443063A (zh) * | 2011-03-25 | 2013-12-11 | 日油株式会社 | 用于生产含羟基缩醛化合物的方法 |
CN106233207A (zh) * | 2014-04-25 | 2016-12-14 | 日产化学工业株式会社 | 抗蚀剂下层膜形成用组合物以及使用该组合物的抗蚀剂图案的形成方法 |
Families Citing this family (171)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9721367D0 (en) * | 1997-10-09 | 1997-12-10 | Univ Liverpool | Delivery system |
JP2001048978A (ja) | 1999-08-04 | 2001-02-20 | Nano Career Kk | オキサゾリン由来のポリマーセグメントを有するブロックコポリマー |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US7682647B2 (en) * | 1999-09-03 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of a drug eluting implantable medical device |
JP2001131271A (ja) * | 1999-11-04 | 2001-05-15 | Kazunori Kataoka | ポリマーミセルの層の積層した表面およびその作成方法 |
CA2389917A1 (en) | 1999-11-04 | 2001-05-10 | Kazunori Kataoka | A polymer micelle as monolayer or layer-laminated surface |
JP2001208754A (ja) * | 2000-01-26 | 2001-08-03 | Kazunori Kataoka | 生物学的な被検体を検出するための組成物 |
US6927033B2 (en) | 2000-05-11 | 2005-08-09 | Toudai Tlo, Ltd. | Polymer composition for forming surface of biosensor |
US7682648B1 (en) | 2000-05-31 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for forming polymeric coatings on stents |
US6451373B1 (en) | 2000-08-04 | 2002-09-17 | Advanced Cardiovascular Systems, Inc. | Method of forming a therapeutic coating onto a surface of an implantable prosthesis |
US6953560B1 (en) | 2000-09-28 | 2005-10-11 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US6824559B2 (en) * | 2000-12-22 | 2004-11-30 | Advanced Cardiovascular Systems, Inc. | Ethylene-carboxyl copolymers as drug delivery matrices |
US6663662B2 (en) * | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US6780424B2 (en) * | 2001-03-30 | 2004-08-24 | Charles David Claude | Controlled morphologies in polymer drug for release of drugs from polymer films |
US6712845B2 (en) * | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6656506B1 (en) * | 2001-05-09 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Microparticle coated medical device |
WO2002096977A1 (fr) * | 2001-05-30 | 2002-12-05 | Nanocarrier Co., Ltd. | Procede de liaison d'une substance a incorporer a une terminaison polymere |
US6881484B2 (en) | 2001-05-30 | 2005-04-19 | Mitsubishi Kagaku Iatron, Inc. | Core-shell particle including signal-generating substance enclosed therein and process for producing the same |
US6743462B1 (en) | 2001-05-31 | 2004-06-01 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for coating implantable devices |
US7094810B2 (en) * | 2001-06-08 | 2006-08-22 | Labopharm, Inc. | pH-sensitive block copolymers for pharmaceutical compositions |
US6939564B2 (en) * | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US6695920B1 (en) | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
CA2450949C (en) * | 2001-06-28 | 2009-04-28 | John Samuel | Methods and compositions for polyene antibiotics with reduced toxicity |
JP4063510B2 (ja) * | 2001-07-13 | 2008-03-19 | ナノキャリア株式会社 | 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤 |
EP1428871B1 (en) | 2001-07-26 | 2008-08-27 | Transparent Inc. | Cultured cell construct containing spheroids of cultured animal cells and utilization thereof |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US7285304B1 (en) | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7989018B2 (en) | 2001-09-17 | 2011-08-02 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7223282B1 (en) * | 2001-09-27 | 2007-05-29 | Advanced Cardiovascular Systems, Inc. | Remote activation of an implantable device |
US6753071B1 (en) | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
US6709514B1 (en) * | 2001-12-28 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Rotary coating apparatus for coating implantable medical devices |
EP1489415A4 (en) * | 2002-03-11 | 2006-02-22 | Toudai Tlo Ltd | POLY (ETHYLENE OXIDE) SURFACE WITH BRUSH TYPE STRUCTURE HAVING HIGH DENSITY |
US7919075B1 (en) | 2002-03-20 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices |
US20040005351A1 (en) * | 2002-03-29 | 2004-01-08 | Kwon Glen S. | Polymeric micelle formulations of hydrophobic compounds and methods |
US7033602B1 (en) | 2002-06-21 | 2006-04-25 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7217426B1 (en) | 2002-06-21 | 2007-05-15 | Advanced Cardiovascular Systems, Inc. | Coatings containing polycationic peptides for cardiovascular therapy |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7056523B1 (en) | 2002-06-21 | 2006-06-06 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine |
US7087263B2 (en) * | 2002-10-09 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Rare limiting barriers for implantable medical devices |
WO2004034992A2 (en) * | 2002-10-15 | 2004-04-29 | Wisconsin Alumni Research Foundation | Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
US6896965B1 (en) | 2002-11-12 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Rate limiting barriers for implantable devices |
US6982004B1 (en) | 2002-11-26 | 2006-01-03 | Advanced Cardiovascular Systems, Inc. | Electrostatic loading of drugs on implantable medical devices |
US7758880B2 (en) | 2002-12-11 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Biocompatible polyacrylate compositions for medical applications |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US7074276B1 (en) | 2002-12-12 | 2006-07-11 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US20060002968A1 (en) | 2004-06-30 | 2006-01-05 | Gordon Stewart | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US6926919B1 (en) * | 2003-02-26 | 2005-08-09 | Advanced Cardiovascular Systems, Inc. | Method for fabricating a coating for a medical device |
US7563483B2 (en) * | 2003-02-26 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | Methods for fabricating a coating for implantable medical devices |
US7063884B2 (en) | 2003-02-26 | 2006-06-20 | Advanced Cardiovascular Systems, Inc. | Stent coating |
US7279174B2 (en) | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7056591B1 (en) * | 2003-07-30 | 2006-06-06 | Advanced Cardiovascular Systems, Inc. | Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same |
US7431959B1 (en) | 2003-07-31 | 2008-10-07 | Advanced Cardiovascular Systems Inc. | Method and system for irradiation of a drug eluting implantable medical device |
US7645474B1 (en) | 2003-07-31 | 2010-01-12 | Advanced Cardiovascular Systems, Inc. | Method and system of purifying polymers for use with implantable medical devices |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US7441513B1 (en) | 2003-09-26 | 2008-10-28 | Advanced Cardiovascular Systems, Inc. | Plasma-generated coating apparatus for medical devices and a method of coating deposition |
US7318932B2 (en) * | 2003-09-30 | 2008-01-15 | Advanced Cardiovascular Systems, Inc. | Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US7704544B2 (en) * | 2003-10-07 | 2010-04-27 | Advanced Cardiovascular Systems, Inc. | System and method for coating a tubular implantable medical device |
US7329413B1 (en) * | 2003-11-06 | 2008-02-12 | Advanced Cardiovascular Systems, Inc. | Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
US7560492B1 (en) | 2003-11-25 | 2009-07-14 | Advanced Cardiovascular Systems, Inc. | Polysulfone block copolymers as drug-eluting coating material |
US7807722B2 (en) * | 2003-11-26 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Biobeneficial coating compositions and methods of making and using thereof |
US7220816B2 (en) | 2003-12-16 | 2007-05-22 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same |
US7435788B2 (en) | 2003-12-19 | 2008-10-14 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US8309112B2 (en) * | 2003-12-24 | 2012-11-13 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
JPWO2005073370A1 (ja) * | 2004-01-31 | 2008-01-10 | 株式会社トランスパレント | 酵素複合体 |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8551512B2 (en) | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US7563780B1 (en) | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US20050287184A1 (en) | 2004-06-29 | 2005-12-29 | Hossainy Syed F A | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US7494665B1 (en) | 2004-07-30 | 2009-02-24 | Advanced Cardiovascular Systems, Inc. | Polymers containing siloxane monomers |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US7311980B1 (en) | 2004-08-02 | 2007-12-25 | Advanced Cardiovascular Systems, Inc. | Polyactive/polylactic acid coatings for an implantable device |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7244443B2 (en) | 2004-08-31 | 2007-07-17 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US7166680B2 (en) | 2004-10-06 | 2007-01-23 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
EP2502941A1 (en) * | 2004-10-25 | 2012-09-26 | Intezyne Technologies Inc. | Heterobifunctional poly (ethylene glycol) and uses thereof |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US7481835B1 (en) | 2004-10-29 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Encapsulated covered stent |
US7390497B2 (en) | 2004-10-29 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US7214759B2 (en) | 2004-11-24 | 2007-05-08 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same |
US7588642B1 (en) | 2004-11-29 | 2009-09-15 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method using a brush assembly |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US7604818B2 (en) | 2004-12-22 | 2009-10-20 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US7419504B2 (en) | 2004-12-27 | 2008-09-02 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US7202325B2 (en) | 2005-01-14 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles |
CN101137700B (zh) * | 2005-03-09 | 2012-07-18 | 东丽株式会社 | 微粒及医药组合物 |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
PT2656840E (pt) | 2005-06-09 | 2016-01-20 | Univ Tokyo | Métodos para produção de compostos de coordenação de complexos de platina |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US7591841B2 (en) | 2005-12-16 | 2009-09-22 | Advanced Cardiovascular Systems, Inc. | Implantable devices for accelerated healing |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US7638156B1 (en) | 2005-12-19 | 2009-12-29 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for selectively coating a medical article |
US20070196428A1 (en) | 2006-02-17 | 2007-08-23 | Thierry Glauser | Nitric oxide generating medical devices |
US7601383B2 (en) | 2006-02-28 | 2009-10-13 | Advanced Cardiovascular Systems, Inc. | Coating construct containing poly (vinyl alcohol) |
US8592385B2 (en) | 2006-03-01 | 2013-11-26 | The University Of Tokyo | Polymer micelle complex including nucleic acid |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
WO2007102608A1 (ja) * | 2006-03-06 | 2007-09-13 | Nanocarrier Co., Ltd. | 疎水性化合物の安定化剤 |
EP2011516A4 (en) | 2006-04-24 | 2010-06-23 | Nanocarrier Co Ltd | PROCESS FOR THE PRODUCTION OF A POLYMERIC MICELLE THAT CONTAINS A CHEMICAL PRODUCT OF LOW MOLECULAR WEIGHT ENCAPSULATED IN IT |
EP2010475A2 (en) | 2006-04-27 | 2009-01-07 | Intezyne Technologies Incorporated | Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8778376B2 (en) | 2006-06-09 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8114150B2 (en) | 2006-06-14 | 2012-02-14 | Advanced Cardiovascular Systems, Inc. | RGD peptide attached to bioabsorbable stents |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US8685430B1 (en) | 2006-07-14 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Tailored aliphatic polyesters for stent coatings |
US8147868B2 (en) | 2006-07-18 | 2012-04-03 | Nanocarrier Co., Ltd. | Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
MX2009003092A (es) * | 2006-09-22 | 2009-05-08 | Labopharm Inc | Composiciones y metodos para suministro de farmaco dirigido a ph. |
JP5271715B2 (ja) | 2006-11-22 | 2013-08-21 | 国立大学法人 東京大学 | ジスルフィド架橋高分子ミセルを用いた環境応答性siRNAキャリア |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
WO2008151019A1 (en) * | 2007-05-30 | 2008-12-11 | University Of Florida Research Foundation, Inc. | Extended release of bioactive molecules from silicone hydrogels |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US8075909B2 (en) * | 2007-09-04 | 2011-12-13 | University Of Florida Research Foundation, Incorporated | Contact lens based bioactive agent delivery system |
EP2284210B1 (en) | 2008-04-30 | 2017-12-06 | The University of Tokyo | Charge conversional ternary polyplex |
WO2009133647A1 (ja) * | 2008-05-02 | 2009-11-05 | 国立大学法人筑波大学 | 高分子化環状二トロキシドラジカル化合物およびその使用 |
WO2009157279A1 (ja) * | 2008-06-24 | 2009-12-30 | ナノキャリア株式会社 | シスプラチン配位化合物の液体組成物 |
WO2009157561A1 (ja) | 2008-06-26 | 2009-12-30 | 独立行政法人科学技術振興機構 | Mri造影能を有する重合体-金属錯体複合体、並びにそれを用いたmri造影用及び/又は抗腫瘍用組成物 |
CA2775747A1 (en) | 2009-10-07 | 2011-04-14 | Sanford Burnham Medical Research Institute | Methods and compositions related to clot-binding lipid compounds |
JP4829351B2 (ja) | 2010-02-05 | 2011-12-07 | ナノキャリア株式会社 | 易崩壊型ポリマーミセル組成物 |
US8685433B2 (en) | 2010-03-31 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
JP2013525285A (ja) | 2010-04-08 | 2013-06-20 | サンフォード−バーナム メディカル リサーチ インスティテュート | 化合物の送達を増強するための方法および組成物 |
JP5843763B2 (ja) | 2010-05-21 | 2016-01-13 | 国立研究開発法人科学技術振興機構 | 物質内包ベシクル及びその製造方法 |
CA2804815C (en) | 2010-07-09 | 2016-06-07 | The University Of Tokyo | Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery |
CA2819635A1 (en) | 2010-12-01 | 2012-06-07 | Spinal Modulation, Inc. | Directed delivery of agents to neural anatomy |
WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
JP5982798B2 (ja) * | 2011-12-01 | 2016-08-31 | 三菱レイヨン株式会社 | ポリエステル(メタ)アクリレートの製造方法 |
EP2962752A4 (en) | 2013-03-01 | 2016-09-07 | Japan Science & Tech Agency | VESICLE CONTAINING A SUBSTANCE, AND PROCESS FOR PRODUCING THE SAME |
RU2015153913A (ru) | 2013-05-17 | 2017-06-22 | Нанокэрриер Ко., Лтд. | Полимерная мицеллярная фармацевтическая композиция |
JP2015046867A (ja) | 2013-07-31 | 2015-03-12 | 株式会社リコー | 撮像装置 |
JP6108369B2 (ja) | 2013-08-06 | 2017-04-05 | 国立研究開発法人科学技術振興機構 | 核酸内包高分子ミセル複合体及びその製造方法 |
US9801958B2 (en) | 2013-08-23 | 2017-10-31 | The University Of Tokyo | Polymer nanoparticle composite and composition for MRI imaging including same |
JP5971264B2 (ja) | 2014-01-10 | 2016-08-17 | Jfeスチール株式会社 | 極厚肉油井管用ねじ継手 |
US10500246B2 (en) | 2015-06-25 | 2019-12-10 | Sanford Burnham Prebys Medical Discovery Institute | Compositions for delivery to and treatment of atherosclerotic plaques |
WO2018204392A1 (en) | 2017-05-02 | 2018-11-08 | Stanford Burnham Prebys Medical Discovery Institute | Tumor associated monocyte/macrophage binding peptide and methods of use thereof |
CA3127985A1 (en) | 2019-02-04 | 2020-08-13 | University Of Tartu | Bi-specific extracellular matrix binding peptides and methods of use thereof |
WO2023068347A1 (ja) * | 2021-10-22 | 2023-04-27 | 株式会社クラレ | β-メチル-δ-バレロラクトン系重合体の製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4039193A1 (de) * | 1990-12-08 | 1992-06-11 | Bayer Ag | In wasser dispergierbare, elektrolytstabile polyetherester-modifizierte polyurethanionomere |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
FR2678168B1 (fr) * | 1991-06-28 | 1993-09-03 | Rhone Poulenc Rorer Sa | Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge. |
-
1996
- 1996-04-18 AU AU53468/96A patent/AU5346896A/en not_active Abandoned
- 1996-04-18 SI SI9620067A patent/SI9620067A/sl not_active IP Right Cessation
- 1996-04-18 BR BR9608330-1A patent/BR9608330A/pt not_active IP Right Cessation
- 1996-04-18 WO PCT/JP1996/001057 patent/WO1996033233A1/ja active IP Right Grant
- 1996-04-18 KR KR1019970707384A patent/KR19990007861A/ko active IP Right Grant
- 1996-04-18 RU RU97119062/04A patent/RU2169742C2/ru active
- 1996-04-18 EP EP96910195A patent/EP0822217B1/en not_active Expired - Lifetime
- 1996-04-18 JP JP53161996A patent/JP3855279B2/ja not_active Expired - Lifetime
- 1996-04-18 NZ NZ305471A patent/NZ305471A/en unknown
- 1996-04-18 US US08/930,898 patent/US5925720A/en not_active Expired - Lifetime
- 1996-04-18 AT AT96910195T patent/ATE226603T1/de not_active IP Right Cessation
- 1996-04-18 HU HU9801633A patent/HUP9801633A3/hu unknown
- 1996-04-18 CA CA002218495A patent/CA2218495A1/en not_active Abandoned
- 1996-04-18 CN CN96194818A patent/CN1085987C/zh not_active Expired - Lifetime
- 1996-04-18 DE DE69624475T patent/DE69624475T2/de not_active Expired - Lifetime
-
1997
- 1997-10-10 NO NO19974678A patent/NO314762B1/no not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103443063A (zh) * | 2011-03-25 | 2013-12-11 | 日油株式会社 | 用于生产含羟基缩醛化合物的方法 |
US8952203B2 (en) | 2011-03-25 | 2015-02-10 | Nof Corporation | Method for manufacturing hydroxyl group-containing acetal compound |
CN103443063B (zh) * | 2011-03-25 | 2015-11-25 | 日油株式会社 | 用于生产含羟基缩醛化合物的方法 |
CN106233207A (zh) * | 2014-04-25 | 2016-12-14 | 日产化学工业株式会社 | 抗蚀剂下层膜形成用组合物以及使用该组合物的抗蚀剂图案的形成方法 |
CN106233207B (zh) * | 2014-04-25 | 2020-04-10 | 日产化学工业株式会社 | 抗蚀剂下层膜形成用组合物以及使用该组合物的抗蚀剂图案的形成方法 |
Also Published As
Publication number | Publication date |
---|---|
KR19990007861A (ko) | 1999-01-25 |
CA2218495A1 (en) | 1996-10-24 |
NO974678D0 (no) | 1997-10-10 |
US5925720A (en) | 1999-07-20 |
SI9620067A (sl) | 1998-06-30 |
MX9708025A (es) | 1998-07-31 |
CN1085987C (zh) | 2002-06-05 |
DE69624475D1 (de) | 2002-11-28 |
HUP9801633A2 (hu) | 1998-11-30 |
RU2169742C2 (ru) | 2001-06-27 |
NZ305471A (en) | 2000-02-28 |
BR9608330A (pt) | 1999-11-30 |
JP3855279B2 (ja) | 2006-12-06 |
AU5346896A (en) | 1996-11-07 |
DE69624475T2 (de) | 2003-05-28 |
ATE226603T1 (de) | 2002-11-15 |
NO314762B1 (no) | 2003-05-19 |
HUP9801633A3 (en) | 1999-03-01 |
EP0822217A1 (en) | 1998-02-04 |
NO974678L (no) | 1997-12-02 |
EP0822217B1 (en) | 2002-10-23 |
WO1996033233A1 (fr) | 1996-10-24 |
EP0822217A4 (en) | 2000-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1085987C (zh) | 杂远螯嵌段共聚物及其制备方法 | |
CN1226332C (zh) | 作为药物载体的带负电荷的两亲嵌段共聚物及其与带正电荷的药物的配合物 | |
CN100349963C (zh) | 作为药物输送媒介物的多分支多肽-聚(乙二醇)嵌段共聚物 | |
CN1085690C (zh) | 一端为糖基,另一端为不同官能基的聚氧乙烯及其制造方法 | |
CN1146408C (zh) | 聚(丙二酸亚甲基酯)微球体、其制备方法及其药物组合物 | |
US20030050426A1 (en) | Functionalized degradable polymers | |
CN1260294C (zh) | pH敏感的可生物降解的聚乳酸衍生物形成的聚合物胶束及其在不良水溶性药物传输上的应用 | |
Bizzarri et al. | Synthesis and characterization of new malolactonate polymers and copolymers for biomedical applications | |
CN1668257A (zh) | 可生物降解的三嵌段共聚物,它们的合成方法和从它制得的水凝胶和生物材料 | |
CN1197396A (zh) | 共聚物胶束药物组合物及其制备方法 | |
Acemoglu et al. | Novel bioerodible poly (hydroxyalkylene carbonates) s: a versatile class of polymers for medical and pharmaceutical applications | |
Rieger et al. | Lactone end-capped poly (ethylene oxide) as a new building block for biomaterials | |
CN1774450A (zh) | 交联的多糖组合物 | |
CN1800238A (zh) | 有生物功能的脂肪族聚酯—聚氨基酸共聚物及合成方法 | |
CN1993400A (zh) | 能够溶胶-凝胶转变的可生物降解的多嵌段聚合物组合物 | |
Cho et al. | Functionalizable Hydrophilic Polycarbonate, Poly (5-methyl-5-(2-hydroxypropyl) aminocarbonyl-1, 3-dioxan-2-one), Designed as a Degradable Alternative for PHPMA and PEG | |
CN101045793A (zh) | 形成交联的聚合物凝胶的方法 | |
CN101050243A (zh) | 一种两亲性壳聚糖衍生物及其制备方法和在药剂学中的应用 | |
CN1735418A (zh) | 微胶粒聚集体 | |
Coudane et al. | Poly (ε-caprolactone)-based graft copolymers: synthesis methods and applications in the biomedical field: a review | |
CN1176137C (zh) | 多臂树杈型功能化聚乙二醇制备方法及它在药物中的应用 | |
CN1765880A (zh) | 含尿烷键的二醇(甲基)丙烯酸酯化合物、其制备方法及其聚合物 | |
US8642502B2 (en) | Reversible gel-forming compositions for controlled delivery of bioactive substances | |
CN1303130C (zh) | 聚合性多支链聚酯的制造方法 | |
CN1146466A (zh) | 生物降解性聚酯材料的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term |
Granted publication date: 20020605 |
|
EXPY | Termination of patent right or utility model |